ACTRN12617000505303已完成未知
A double-blind placebo-controlled trial investigating the efficacy of interferential therapy using two different electrode placements on low back pain.
Prince Sultan Military College of Health Science0 个研究点目标入组 160 人开始时间: 2017年4月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A double blind placebo controlled trial investigating the efficacy of Clopidogrel as prophylactic treatment for migrane. - Clopidogrel as prophylactic treatment for migraneMigraineEUCTR2008-001604-23-GBGuy's & St Thomas' NHS Foundation Trust286
进行中（未招募）
1 期
Double-blind, placebo-controlled trial investigating the safety of re-exposure to 900 mg of Org 34517, used as adjunctive therapy in subjects with psychotic major depression (major depressive episode, severe, with psychotic features), who participated in Trial 28130Psychotic major depression (major depressive episode, severe, with psychotic features)MedDRA version: 6.1Level: LLTClassification code 10037250EUCTR2004-002156-34-CZV Organon60
进行中（未招募）
不适用
Placebo-controlled double-blind trial investigating the efficacy and tolerability of Posterisan® akut with lidocaine 60 mg/suppository in abatement of complaints associated with hemorrhoidsRelief of complaints associated with hemorrhoids (pain, burning, itching)MedDRA version: 14.1Level: HLTClassification code 10002580Term: Anorectal therapeutic proceduresSystem Organ Class: 100000004865EUCTR2012-002083-27-DEDr. Kade Pharmazeutische Fabrik GmbH
进行中（未招募）
不适用
Placebo-controlled double-blind trial investigating the efficacy and tolerability of Posterisan® akut with lidocaine (50 mg/g rectal ointment) in abatement of complaints associated with the anorectal symptom complexRelief of complaints associated with anorectal symptom complex (pain, burning, itching)MedDRA version: 14.1Level: HLTClassification code 10002580Term: Anorectal therapeutic proceduresSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-006283-42-DEDr. Kade Pharmazeutische Fabrik GmbH
进行中（未招募）
不适用
A double-blind, placebo-controlled, clinical study examining the effect of QAW039 capsules on lung function and Astma control in non-atopic, asthmatic patients with a baseline lung function of 40-80% predicted, inadequately controlled with low dose therapy with inhaled corticosteroidsModerate-to-severe, persistent asthma, inadequately controlledwith ICS therapy.MedDRA version: 18.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2012-003995-38-CZovartis Pharma Services AG530